Physician profile

Christopher G Meyer

Vascular Surgery · Winter Park, FL

NPI 1134176571

$672.28

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$540.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Depuy Synthes Products, INC. $432.17 2023 Velys
Bard Peripheral Vascular, INC. $115.69 2020-2021
Boston Scientific Corporation $44.63 2021-2023 Varithena Administration Pack
Cook Medical LLC $41.88 2024 Zilver Ptx, Cook Celect
Cashflow Solutions, LLC $19.20 2023 Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt
Medtronic, INC. $18.71 2023 Venaseal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher G Meyer

$672.28

in general payments reported 2019-2025

Years
2020-2024
Top company
Depuy Synthes Products, INC.

https://glasscript.com/doctor/5660/christopher-g-meyer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.